Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma

sonderdruck aus: Therapeutic advances in medical oncology | 2021

von Jun, T. | Ozbek, U. | Dharmapuri, S. | +22

Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: adjunctive role of the ALBI grade

sonderdruck aus: Cancers | 2020

von Pinato, D. | Kaneko, T. | Bettinger, D. | +3